Hematopoietic cell transplantation-specific comorbidity index to predict non-relapse mortality and survival after allografting.

被引：1
|
作者：
Kato, R [1 ]
Fukuda, T [1 ]
Usui, E [1 ]
Yamasaki, S [1 ]
Maruyama, D [1 ]
Morita, Y [1 ]
Kim, SW [1 ]
Mori, SI [1 ]
Tanosaki, R [1 ]
Tajima, K [1 ]
Heike, Y [1 ]
Makimoto, A [1 ]
Tobinai, K [1 ]
Takaue, Y [1 ]
机构：
[1] Natl Canc Ctr, Hematopoiet Cell Transplantat Unit, Tokyo, Japan
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.2731.2731
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2731
引用
收藏
页码：766A / 767A
页数：2
相关论文
共 50 条
  • [21] Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR
    F V Michelis
    E G Atenafu
    V Gupta
    D D Kim
    J Kuruvilla
    A Lambie
    J H Lipton
    D Loach
    H A Messner
    Bone Marrow Transplantation, 2013, 48 : 1450 - 1455
  • [22] Comorbidity, History of Alcohol Disorders, and LDH Predict Non-Relapse Mortality (NRM) Among Recipients of Autologous Hematopoietic Cell Transplantation (HCT) for Lymphoma
    Vaughn, Jennifer Eliece
    Storer, Barry E.
    Chauncey, Thomas
    Gopal, Ajay K.
    Holmberg, Leona
    Bensinger, William
    Maloney, David G.
    Press, Oliver W.
    Storb, Rainer F.
    Sorror, Mohamed L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S66 - S67
  • [23] Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR
    Michelis, F. V.
    Atenafu, E. G.
    Gupta, V.
    Kim, D. D.
    Kuruvilla, J.
    Lambie, A.
    Lipton, J. H.
    Loach, D.
    Messner, H. A.
    BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1450 - 1455
  • [24] Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population
    Alsugair, Ali
    Ahmed, Syed O.
    Sharif, Mohamed Isam
    Elhassan, Tusneem
    Alzahrani, Hazza A.
    Almhareb, Fahed
    Chaudhri, Naeem A.
    Alsharif, Fahad
    Rasheed, Walid
    Hanbali, Amr
    Alfraih, Feras Abdulaziz
    Shaheen, Marwan
    El Fakih, Riad
    Alhayli, Saud
    Alahmari, Ali
    Alshaibani, Alfadel
    Albabtain, Abdulwahab
    Alotaibi, Ahmad S.
    Alfayez, Mansour
    Aljurf, Mahmoud
    BLOOD, 2022, 140 : 10566 - 10567
  • [25] MINOR ABO MISMATCH IS ASSOCIATED WITH INCREASED NON-RELAPSE MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Alimoghaddam, K.
    Logan, A. C.
    Wong, R.
    Weiss, S.
    Fontaine, M.
    Arai, S.
    Grumet, C.
    Miklos, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S285 - S286
  • [26] ASSOCIATION BETWEEN THE HEMATOPOIETIC CELL TRANSPLANTATION-SPECIFIC COMORBIDITY INDEX (CIN) AND NON-RELAPSE MORTALITY (NRM) AFTER REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1)
    Mohty, M.
    Labopin, M.
    Basara, N.
    Cornelissen, J.
    Tabrizi, R.
    Malm, C.
    Perez-Simon, J. A.
    Nagler, A.
    Kroger, N.
    Rio, B.
    Martino, R.
    Eder, M.
    Bilger, K.
    Bunjes, D. W.
    Socie, G.
    Blaise, D.
    Polge, E.
    Rocha, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S281 - S281
  • [27] Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)
    Mohty, Mohamad
    Labopin, Myriam
    Basara, Nadezda
    Cornelissen, Jan J.
    Tabrizi, Reza
    Malm, Claes
    Perez Simon, Jose Antonio
    Nagler, Arnon
    Kroger, Nicolaus
    Rio, Bernard
    Martino, Rodrigo
    Eder, Matthias
    Bilger, Karin
    Bunjes, Donald W.
    Socie, Gerard
    Blaise, Didier
    Polge, Emmanuelle
    Rocha, Vanderson
    BLOOD, 2009, 114 (22) : 270 - 270
  • [28] Relevance of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) On Non-Relapse Related Mortality (NRM) in Patients with Acute Lymphoblastic Leukemia (ALL) Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Complete Remission: Results From the GMALL Study Group
    Stelljes, Matrhias
    David, Mareike
    Arnold, Renate
    Beelen, Dietrich W.
    Bethge, Wolfgang A.
    Bornhaeuser, Martin
    Dengler, Jolanta
    Finke, Juergen
    Kolb, Hans J.
    Kolbe, Karin
    Kroeger, Nicolaus
    Niederwieser, Dietger
    Roesler, Wolf
    Schwerdtfeger, Rainer
    Kienast, Joachim
    Goekbuget, Nicola
    Hoelzer, Dieter
    BLOOD, 2009, 114 (22) : 1301 - 1301
  • [29] The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation
    Elias, Shlomo
    Brown, Samantha
    Devlin, Sean M.
    Barker, Juliet N.
    Cho, Christina
    Chung, David J.
    Dahi, Parastoo B.
    Giralt, Sergio
    Gyurkocza, Boglarka
    Jakubowski, Ann A.
    Lahoud, Oscar B.
    Landau, Heather
    Lin, Richard J.
    Papadopoulos, Esperanza B.
    Politikos, Ioannis
    Ponce, Doris M.
    Scordo, Michael
    Shaffer, Brian C.
    Shah, Gunjan L.
    Tamari, Roni
    Young, James W.
    Perales, Miguel-Angel
    Shouval, Roni
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 840 - 851
  • [30] Usefulness of a simplified scoring system to predict early non-relapse mortality after stem cell transplantation
    Balsalobre, P.
    Munoz, C.
    Serrano, D.
    Gayoso, J.
    Rodriguez, G.
    Buno, I.
    Martinez, Y.
    Gomez-Pineda, A.
    Diez-Martin, J. L.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S172 - S172
12345